Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
4,999,149
-
Shares change
-
+124,267
-
Total reported value, excl. options
-
$230,849,125
-
Value change
-
+$7,127,231
-
Number of buys
-
51
-
Number of sells
-
-31
-
Price
-
$46.21
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q4 2021
103 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q4 2021.
IRADIMED CORP - Common Stock (IRMD) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,999,149 shares
of 12,733,410 outstanding shares and own 39.26% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (730,659 shares), RENAISSANCE TECHNOLOGIES LLC (693,312 shares), Soleus Capital Management, L.P. (450,030 shares), BlackRock Inc. (420,094 shares), VANGUARD GROUP INC (309,561 shares), Russell Investments Group, Ltd. (228,288 shares), Ranger Investment Management, L.P. (181,736 shares), RK Capital Management, LLC (145,600 shares), RICE HALL JAMES & ASSOCIATES, LLC (129,930 shares), and RESOURCE CONSULTING GROUP INC (128,000 shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.